OC
ECAT icon

Oppenheimer & Co’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History

Oppenheimer & Co’s Portfolio ECAT Stock Details ECAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.71M Sell
199,231
-9,865
-5% -$148K 0.03% 499
2025
Q4 		$3.22M Sell
209,096
-3,882
-2% -$62.2K 0.05% 412
2025
Q3 		$3.49M Sell
212,978
-84,021
-28% -$1.38M 0.04% 431
2025
Q2 		$4.77M Buy
296,999
+20,676
+7% +$321K 0.06% 327
2025
Q1 		$4.36M Buy
276,323
+7,862
+3% +$130K 0.07% 323
2024
Q4 		$4.4M Sell
268,461
-6,064
-2% -$105K 0.07% 322
2024
Q3 		$4.87M Buy
274,525
+2,805
+1% +$48.8K 0.07% 292
2024
Q2 		$4.77M Buy
271,720
+183,911
+209% +$3.13M 0.08% 289
2024
Q1 		$1.52M Buy
87,809
+10,474
+14% +$175K 0.03% 600
2023
Q4 		$1.25M Buy
77,335
+54,553
+239% +$831K 0.02% 641
2023
Q3 		$337K Buy
22,782
+758
+3% +$11.7K 0.01% 1094
2023
Q2 		$345K Buy
22,024
+9,928
+82% +$154K 0.01% 1112
2023
Q1 		$189K Buy
12,096
+37
+0.3% +$540 ﹤0.01% 1268
2022
Q4 		$162K Buy
+12,059
New +$165K ﹤0.01% 1252

Other funds holding ECAT

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Oppenheimer & Co's ECAT Position: Q1 2026 in Review

Oppenheimer & Co reduced its BlackRock ESG Capital Allocation Term Trust (ECAT) stake by 4.7% in Q1 2026, selling an estimated $148K and leaving 199,231 shares worth $2.71M. The position accounts for 0.03% of the portfolio, ranked #499.

Oppenheimer & Co first reported a position in ECAT in Q4 2022 and has held it in 14 quarters since. The position peaked at $4.87M in Q3 2024. 84 funds tracked by Wall St. Rank hold ECAT as of Q1 2026.

  • Oppenheimer & Co held 199,231 shares of BlackRock ESG Capital Allocation Term Trust worth $2.71M as of Q1 2026.
  • Oppenheimer & Co sold 9,865 BlackRock ESG Capital Allocation Term Trust shares in Q1 2026, an estimated $148K.
  • BlackRock ESG Capital Allocation Term Trust made up 0.03% of Oppenheimer & Co's portfolio in Q1 2026, its #499 holding.
  • Oppenheimer & Co first reported a position in BlackRock ESG Capital Allocation Term Trust in Q4 2022 and has held it in 14 quarters since.
  • Oppenheimer & Co's BlackRock ESG Capital Allocation Term Trust position peaked at $4.87M in Q3 2024.
  • 84 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.